BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11965407)

  • 1. [Buspirone increases D2-like dopaminergic receptor density in rat corpus striatum].
    Lima VT; Macedo DS; Nogueira CR; Vasconcelos SM; Viana GS; Sousa FC
    Arq Neuropsiquiatr; 2002 Mar; 60(1):38-40. PubMed ID: 11965407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of one-week ethanol treatment on monoamine levels and dopaminergic receptors in rat striatum.
    Vasconcelos SM; Macêdo DS; Lima LO; Sousa FC; Fonteles MM; Viana GS
    Braz J Med Biol Res; 2003 Apr; 36(4):503-9. PubMed ID: 12700829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T; Kusumi I; Matsubara R; Matsubara S; Koyama T
    Eur J Pharmacol; 1997 Feb; 321(2):163-9. PubMed ID: 9063684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of haloperidol and two anxiolytic drugs, buspirone and lesopitron, on c-Fos expression in the rat striatum and nucleus accumbens.
    Palacios G; Muro MA; Paz Marín A
    Brain Res; 1996 Dec; 742(1-2):141-8. PubMed ID: 9117387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
    Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine D1-like receptors have higher affinity for dopamine in ethanol-treated rats.
    May T
    Eur J Pharmacol; 1992 May; 215(2-3):313-6. PubMed ID: 1396997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early administration of tiapride to young rats without long-lasting changes in the development of the dopaminergic system.
    Bock N; Moll GH; Wicker M; Pilz J; Rüther E; Banaschewski T; Huether G; Rothenberger A
    Pharmacopsychiatry; 2004 Jul; 37(4):163-7. PubMed ID: 15467972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and serotonin metabolism associated with morphine reward and its inhibition with buspirone: A study in the rat striatum.
    Haleem DJ; Nawaz S; Salman T
    Pharmacol Biochem Behav; 2018 Jul; 170():71-78. PubMed ID: 29782941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cocaine self-administration and extinction on D2 -like and A2A receptor recognition and D2 -like/Gi protein coupling in rat striatum.
    Frankowska M; Marcellino D; Adamczyk P; Filip M; Fuxe K
    Addict Biol; 2013 May; 18(3):455-66. PubMed ID: 22500978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of buspirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and nonstressed rats.
    De Boer SF; Slangen JL; Van der Gugten J
    Pharmacol Biochem Behav; 1991 Feb; 38(2):299-308. PubMed ID: 2057500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.
    Di Ciano P; Cormick PM; Stefan C; Wong E; Kim A; Remington G; Le Foll B
    Psychopharmacology (Berl); 2017 Nov; 234(22):3309-3320. PubMed ID: 28825117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic doses of buspirone block D3 receptors in the living primate brain.
    Kim SW; Fowler JS; Skolnick P; Muench L; Kang Y; Shea C; Logan J; Kim D; Carter P; King P; Alexoff D; Volkow ND
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1257-67. PubMed ID: 24679922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.